BioLamina’s core innovation lies in its proprietary laminins—highly specialized proteins that replicate the natural environment in which human cells grow.
Every year, millions of animals are used in laboratories, and for many people, the image is immediate and uncomfortable: ...
The Federation Cup in Ranchi next month will be the first major national championships where the Athletics Federation of ...
Bringing a single drug to market can take more than a decade and cost billions of dollars, with fewer than one in ten candidates successfully reaching approval. Against this backdrop, generative AI is ...
This session will explore how AI-driven API testing enables teams to handle massive test volumes, complex business logic, and ...
To support this next phase of innovation in AI-driven testing, Applause has appointed Aatish Salvi as Chief Technology Officer. A seasoned technology leader and artificial intelligence expert, Salvi ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Eurofins Scientific SE (the "Company" or "Eurofins") (EUFI.PA) (Paris:ERF) announces the signing of an agreement to divest its Electrical & Electronic Testing business ("MET Labs") to UL Solutions Inc ...
Google DeepMind has introduced a new 10-dimension framework to evaluate AGI, replacing single-score benchmarks with ...
Autism Spectrum Disorder now affects approximately 1 in 31 children in the United States, according to the CDC’s 2025 ADDM ...
The National Association of State Boating Law Administrators (NASBLA) continues to lead national efforts to enhance impaired operator detection through the development and delivery of the seated ...
OCI Collaborate 2 Commercialize Agreement Executed to Fund Proprietary Seasonal Influenza Candidate DevelopmentGuelph, Ontario--(Newsfile Corp. - April 14, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results